Press Releases & News

SAN DIEGO, CA / ACCESSWIRE / August 29, 2019 / Calidi Biotherapeutics Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer announced today, the completion of the adipose tissue collection from healthy donors necessary for isolation of adipose-derived mesenchymal stem cells (AD-MSC) -…

Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of a distinguished innovator in the field of cancer diagnosis and treatment, Ewa Carrier, MD, to their medical and scientific advisory board. Dr. Carrier has…

SAN DIEGO, CA / ACCESSWIRE / July 10, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of stem cell-based delivery of oncolytic virus-based immunotherapies for cancer, today announced an exclusive veterinary worldwide license for the development and commercialization of its lead…

SAN DIEGO (PRWEB) JUNE 03, 2019 - Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of Dr. Dmitriy Zamarin, MD, Ph.D., to their scientific advisory board. Dr. Zamarin is an accomplished medical oncologist who…

SAN DIEGO, May 30, 2019 /PRNewswire/ -- Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive: Dr. Ashok Srivastava, MD, Ph.D., MBA, to their scientific advisory board. Dr. Srivastava's notable achievements include contributions to…

SAN DIEGO, May 28, 2019 /PRNewswire/ -- Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced their ongoing scientific collaboration with David F. Stroncek, M.D., Chief, Cell Therapy Section at the Department of Transfusion Medicine, National Institutes of Health (NIH)…

SAN DIEGO (PRWEB) APRIL 15, 2019 Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced that Allan Camaisa, Calidi Biotherapeutics CEO, and San Diego based serial entrepreneur, was interviewed by San Diego’s local news station KUSI.…

SAN DIEGO, Jan. 3, 2019 /PRNewswire-PRWeb/ -- Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the founding of a scientific and medical advisory board (SMAB). The SMAB will enable Calidi Biotherapeutics to receive critical input…